行情

ALPN

ALPN

Alpine Immune
NASDAQ

实时行情|Nasdaq Last Sale

4.160
-0.080
-1.89%
已收盘, 16:00 09/17 EDT
开盘
4.210
昨收
4.240
最高
4.400
最低
3.980
成交量
8,231
成交额
--
52周最高
8.24
52周最低
3.410
市值
7,732.46万
市盈率(TTM)
-1.3779
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ALPN 新闻

  • 欧洲议会表决通过欧央行行长提名 拉加德10月上任
  • 澎湃新闻.3小时前
  • 德意志银行:年底标普500将大跌13%至2600点
  • 新浪财经综合.3小时前
  • 欧洲8月份汽车销量大幅下滑 行业困境加剧
  • 新浪财经综合.3小时前
  • “脸书”新设独立监督委员会 可否决扎克伯格意见
  • 中国新闻网.4小时前

更多

所属板块

生物技术和医学研究
+0.26%
制药与医学研究
+0.57%

热门股票

名称
价格
涨跌幅

ALPN 简况

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a process known as directed evolution. The vlgD platform exploits both known and unknown interactions at immune synapse through a process called direct evolution for patients living with cancer, autominnue/inflammatory conditions and chronic infectious disease. It optimizes native immune system proteins for use as therapeutics. The Company also developed Transmembrane Immunomodulatory Protien (TIP) technology, based on the vIgD platform, to enhance engineered cellular therapies. TIP program is created to help companies focused on engineered cellular therapies.
展开

Webull提供Alpine Immune Sciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。